Early MS Treatments Impact Relapses And Brain Scarring Differently, But Not Disability

FRIDAY, Oct. 16, 2026— Therapy targeting the immune system’s B cells might offer better odds against relapses in the early stages of multiple sclerosis (MS), a new study reports.People taking IV drugs that lower immune B-cell levels had a 62%...